Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Dec 9;27(12):e976.
doi: 10.1093/oncolo/oyac168.

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma

Alessandro Rizzo  1 , Angela Dalia Ricci  1 , Giovanni Brandi  1
Affiliations
Comment

Neoadjuvant Dovitinib in Early- and Intermediate-Stage Hepatocellular Carcinoma

Alessandro Rizzo et al. Oncologist. .

Abstract

This letter to the editor comments on recently reported results of a phase II study of dovitinib therapy for hepatocellular carcinoma

PubMed Disclaimer

Comment in

Comment on

References

    1. Woei-A-Jin FJSH, Weijl NI, et al. . Neoadjuvant treatment with angiogenesis-inhibitor dovitinib prior to local therapy in hepatocellular carcinoma: a phase II study. The Oncologist. 2021;26(10):854-864. 10.1002/onco.13901 - DOI - PMC - PubMed
    1. Llovet JM, Kelley RK, Villanueva A, et al. . Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. 10.1038/s41572-020-00240-3. - DOI - PubMed
    1. Llovet JM, Castet F, Heikenwalder M, et al. . Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol. 2021. 10.1038/s41571-021-00573-2. - DOI - PubMed
    1. Dikilitas M. Why adjuvant and neoadjuvant therapy failed in HCC. Can the new immunotherapy be expected to be better? J Gastrointest Cancer. 2020;51(4):1193-1196. 10.1007/s12029-020-00497-7. - DOI - PubMed
    1. Pinato DJ, Cortellini A, Sukumaran A, et al. . PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma. BMC Cancer 2021;21(1):301. 10.1186/s12885-021-08033-x. - DOI - PMC - PubMed

MeSH terms